The Voice of Epidemiology

    
    


    Web EpiMonitor

► Home ► About ► News ► Job Bank Events ► Resources ► Contact
 


Columnist Questions The Basis On Which Epidemiology Colleagues Offer Risk Advice Related To COVID-19

Briana Mezuk, the University of Michigan epidemiologist who writes a column entitled “Ask An Epidemiologist” for Psychology Today (see The Epi Monitor, July 2019 issue) raises questions in her most recent column about the basis on which epidemiologists give advice about risk and reopenings and other COVID related matters. She is especially concerned about advice which requires making judgments about tradeoffs as all risk benefit decisions do.

Times Survey Of Epidemiologists

In her column, Mezuk recalls the New York Times article published earlier last summer which surveyed more than 500 epidemiologists to ask them when they expect to fly, hug and do 18 other everyday activities again. She questions whether the respondents in the Times survey were asked about what tradeoffs they were willing to make to stay safe.

According to Mezuk, “…the Times did not conduct a survey of expert opinion. It conducted a litmus test of whether you are the type of person who worries about shark attacks whey you go to the beach or worries about a hijacking when you get on a plane. You don’t need any expertise in epidemiology to give a “valid” response to these questions because the responses have little, if anything, to do with the expertise these people have.”

Evaluating Risk Benefit Advice

Before judging the value of any risk benefit based advice given by epidemiologists or any other experts for that matter, Mezuk gives a sample of the type of questions she would want to have answers to. These additional questions are designed to evaluate a person’s experience, how much control they think they have on their own risk, how accurately they think about the true risks, and whether or not they are pessimistic or optimistic about life in general. These personal and psychological features of an expert’s life are influential in determining what kind of advice is given, especially when data are lacking.

Mezuk concludes there is simply too much dynamic uncertainty about this pandemic to rely on data alone to make decisions. “The takeaway here is that data is cheap, but information is priceless. What is the difference? Information empowers your understanding and decision making. Data, especially data without sufficient context, risks impairing it.”

To read the column, visit: https://bit.ly/3hOcl6b


Reader Comments:
Have a thought or comment on this story ?  Fill out the information below and we'll post it on this page once it's been reviewed by our editors.
 

       
  Name:        Phone:   
  Email:         
  Comment: 
                 
 
       

           


 

 
 
 
      ©  2011 The Epidemiology Monitor

Privacy  Terms of Use  Sitemap

Digital Smart Tools, LLC